Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ADOLOR CORP | 263,747 | reported | 12 Dec 2011 | tx 15+411,250−411,250 |
| Cullinan Therapeutics, Inc. | 38,513 | reported | 12 Jun 2025 | tx 5+97,044 |
| HEARUSA INC | 25,000 | reported | 10 Jun 2010 | tx 3+75,000 |
| Viking Therapeutics, Inc. | 22,000 | reported | 02 Jan 2020 | tx 7+120,786 |
| Nabriva Therapeutics Plc | 20,200 | reported | 23 Jun 2017 | tx 2+30,300 |
| NextCure, Inc. | 18,700 | reported | 20 Jun 2025 | tx 7+116,400 |
| Nabriva Therapeutics AG | 11,447 | reported | 02 Aug 2022 | tx 10+187,100−8,603 |
| TCR2 THERAPEUTICS INC. | 0 | reported | 01 Jun 2023 | tx 8+51,482−51,482 |
| Gritstone Oncology, Inc. | 0 | reported | 04 Apr 2025 | tx 5+110,979−135,979 |
| OPTIMER PHARMACEUTICALS INC | 0 | reported | 24 Oct 2013 | tx 6+185,000−85,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Jun 2025 | GRANT_AWARD | NextCure, Inc. | 18,700 | 0.00 USD | deriv |
| 12 Jun 2025 | GRANT_AWARD | Cullinan Therapeutics, Inc. | 38,513 | 0.00 USD | deriv |
| 04 Apr 2025 | OTHER | Gritstone Oncology, Inc. | 25,000 | 0.00 USD | |
| 04 Apr 2025 | OTHER | Gritstone Oncology, Inc. | 103,600 | 0.00 USD | deriv |
| 04 Apr 2025 | OTHER | Gritstone Oncology, Inc. | 7,379 | 0.00 USD | deriv |
| 26 Jun 2024 | GRANT_AWARD | Cullinan Therapeutics, Inc. | 15,806 | 0.00 USD | deriv |
| 20 Jun 2024 | GRANT_AWARD | NextCure, Inc. | 18,700 | 0.00 USD | deriv |
| 17 Jun 2024 | GRANT_AWARD | Gritstone Oncology, Inc. | 7,379 | 0.00 USD | deriv |
| 26 Apr 2024 | GRANT_AWARD | Gritstone Oncology, Inc. | 103,600 | 0.00 USD | deriv |
| 22 Jun 2023 | GRANT_AWARD | NextCure, Inc. | 14,250 | 0.00 USD | deriv |
| 08 Jun 2023 | GRANT_AWARD | Cullinan Therapeutics, Inc. | 18,450 | 0.00 USD | deriv |
| 01 Jun 2023 | OTHER | TCR2 THERAPEUTICS INC. | 16,800 | 0.00 USD | deriv |
| 01 Jun 2023 | OTHER | TCR2 THERAPEUTICS INC. | 10,482 | 0.00 USD | deriv |
| 01 Jun 2023 | OTHER | TCR2 THERAPEUTICS INC. | 12,100 | 0.00 USD | deriv |
| 01 Jun 2023 | OTHER | TCR2 THERAPEUTICS INC. | 12,100 | 0.00 USD | deriv |
| 15 Dec 2022 | GRANT_AWARD | TCR2 THERAPEUTICS INC. | 16,800 | 0.00 USD | deriv |
| 02 Aug 2022 | SALE | Nabriva Therapeutics AG | 7,826 | 0.19 USD | anomaly |
| 23 Jun 2022 | GRANT_AWARD | NextCure, Inc. | 14,250 | 0.00 USD | deriv |
| 22 Jun 2022 | GRANT_AWARD | Cullinan Therapeutics, Inc. | 16,475 | 0.00 USD | deriv |
| 16 Sept 2021 | GRANT_AWARD | Cullinan Therapeutics, Inc. | 7,800 | 0.00 USD | deriv |
| 09 Dec 2021 | GRANT_AWARD | TCR2 THERAPEUTICS INC. | 12,100 | 0.00 USD | deriv |
| 02 Aug 2021 | SALE | Nabriva Therapeutics AG | 777 | 1.20 USD | anomaly |
| 28 Jul 2021 | GRANT_AWARD | Nabriva Therapeutics AG | 17,500 | 0.00 USD | |
| 28 Jul 2021 | GRANT_AWARD | Nabriva Therapeutics AG | 35,000 | 0.00 USD | deriv |
| 24 Jun 2021 | GRANT_AWARD | NextCure, Inc. | 14,250 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 23 May 2018.